Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
<p>Abstract</p> <p>Background</p> <p>The goal of this study was to determine the effects of a selective Cyclooxygenase (COX)-2 inhibitor on the inhibition of tumor growth and pulmonary metastasis in a Lewis Lung Carcinoma (LLC) animal model.</p> <p>Methods&l...
Main Authors: | Han Jae, Oh Young, Park Won, Pyo Hongryull |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-11-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/27/1/66 |
Similar Items
-
Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in <it>Vitro</it> and in <it>Vivo</it>
by: Dai Zhi-Jun, et al.
Published: (2012-12-01) -
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor on Noise- Induced Hearing Loss
by: Akram Pourbakht
Published: (2013-05-01) -
Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
by: Jun Zhang, et al.
Published: (2011-01-01) -
Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2
by: Tai Y, et al.
Published: (2019-04-01) -
Suppressing Growth and Invasion of Human Hepatocellular Carcinoma Cells by Celecoxib Through Inhibition of Cyclooxygenase-2 [Corrigendum]
by: Tai Y, et al.
Published: (2021-11-01)